Patents by Inventor Jacob JAFFE

Jacob JAFFE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MARKERS FOR EZH2 INHIBITORS
    Publication number: 20160091485
    Abstract: The invention provides methods of detecting an EZH2 mutation and associated epigenetic markers in a cancer cell, methods cancer diagnosis and methods of screening for EZH2 inhibitors.
    Type: Application
    Filed: April 11, 2014
    Publication date: March 31, 2016
    Applicants: THE BROAD INSTITUTE, INC., NOVARTIS AG
    Inventors: Ho Man CHAN, Veronica GIBAJA, Kristy HAAS, Jacob JAFFE, Mariela JASKELIOFF, Frank Peter STEGMEIER, Wei QI
  • MARKERS FOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Publication number: 20150354006
    Abstract: The invention provides methods of detecting a NSD2 mutation in a cancer cell, methods cancer diagnosis and methods of screening for NSD2 inhibitors.
    Type: Application
    Filed: October 15, 2013
    Publication date: December 10, 2015
    Applicants: Novartis AG, Broad Institute, Inc., Dana-Farber Cancer Institute, Inc.
    Inventors: Ho Man CHAN, Nathan P. ENGLUND, Levi GARRAWAY, Min HU, Jacob JAFFE, Gregory KRYUKOV, Jun LIU, Xianghui LIU, Rob MCDONALD, Frank Peter STEGMEIER, Zhaofu WANG, Yan WANG, Haiping WU, Feng YAN